chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Prevnar, daptacel, acthib, ipv on 01/30/04.  Hives on 01/31.  Hives gone by 02/03.  No fever or illness symptoms no irritability.  Cough and runny nose developed 02/07.  No treatment.
In for Hep A vaccine today and reports that left deltoid muscle still sore and tender after BEXSERO given 9-9-16. ROMWNL. No redness or firmness notes to sites. Patient states (L) deltoid muscle became sore 2-3 hours after vaccine given 9-9-16. States that she had "bone" pain up to (L) side of neck and down (L) back, along with (L) deltoid sore. States "bone" pain lasted up to 2-3 days ago. From shoulder to neck. Denies further "bone" pain.
I woke up on the morning of 9/19/2020 with no hearing in left ear.  Completely deaf.
HIVES; HEADACHE; ITCHING; RASH; BURNING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced hives, headache, itching, rash, and burning. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the hives, headache, itching, rash and burning was not reported. This report was non-serious.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no concurrent condition or medical history reported. On an unknown date the patient was vaccinated with improperly stored GARDASIL (lot # J006850, expiration date 31-MAR-2016) (Temperature: 33 Fahrenheit for 144 hours and 34 Fahrenheit for 228 hours) (dosage, strength and route unknown). No adverse symptoms was reported. Additional information has been requested.
Mother called 7/1/15 at 1:00 pm stating her son had received the varicella vaccine a week ago (6/22/15), they noticed a few raised bumps on him a few days later that have turned into a rash all over his body.  He awoke at 2am this morning (7/1/15) itching and his eyes started getting red and swollen.  Mom denies any SOB, scratchy throat, itching ears or any respiratory difficulties.  Advised mom to take him to the ER or minor med to be evaluated by a MD, possibly starting steroids for the itching and rash.  Mom then stated her step son got the varicella shot elsewhere yesterday and is now vomiting; I advised her again to seek medical evaluation to ensure that he was not exposed to something else and having a reaction to that and that I would call her to check up on him in a day or two.  Told her we may possibly fill out a VAERS but not to delay treatment waiting for that.   Mom denies any fever or allergies to any thing else but will take him in to the ER or minor med.
After receiving the Moderna Booster, in the middle of the night, I experienced heart pounding, fatigue, weakness, and not feeling well at all. I have not felt quite right since the vaccination. I started to develop episodes of aches and pains a week ago and still having them. The aches have become more severe.
Headache, Myalgia, Fever,  Nasal congestion, rhinorrhea, chills, fatigue Narrative:
I have history of intermittent episodes of neurological dysfunction, with probable diagnosis of FND. I was symptom-free prior to vaccination today. Within 20?30 minutes my left arm (injection site) began to ache. Shortly after that my face began tingling and my thinking began to feel ?foggy.? By one hour post injection, I was having trouble speaking and walking. These are not brand new symptoms for me, but I do feel the vaccination caused a flare of my dormant symptoms.
fainted two times; felt very tired after the vaccine for several days; This is a spontaneous report from a contactable consumer (patient). A 20-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in left arm on 07Mar2021 11:45 (Lot Number: EN6206) as single dose for Covid-19 immunisation at age 20 years old. Medical history included allergies to penicillin. The patient is not pregnant. The patient had no covid prior to vaccination. There were no concomitant medications. The patient did not receive other vaccine in four weeks and no other medications in two weeks. The patient previously received amoxicillin and experienced allergies. The patient reported that she felt very tired after the vaccine for several days. Four days after she received the vaccine, she took a bath and when she got out of the bath, she fainted two times. She stated that she has never fainted before and she has taken several baths. Onset of the events was on 11Mar2021 21:00. No treatment given for the events. The patient had a covid test (saliva) post vaccination on 15Mar2021 with negative result. The patient recovered from the events.
Intermittent /waxing/waning cough & congestion over 4-5 weeks prior. Had been dx'd with allergic rhinitis and sinusitis prior to vaccine - on antihistamines and antibiotics. Afebrile prior to and after vaccination. In the 48 hrs following vaccination, worsening cough / congestion and work of breathing requiring admission to hospital. Clinically consistent with bronchiolitis. Required brief (~ 36 hr) hospitalization with steroids, bronchodilators, oxygen by nasal cannula, though unlikely reactive airway disease.
skin with mild erythema to left deltoid area. Approximate size 4 X 7 cm, presented 2 days post immunization. Tx: Benadryl PRN, no sequelae.
headache; This non-serious case was reported by a other health professional via sales rep and described the occurrence of headache in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, immediately after receiving Menveo, the patient experienced headache (Verbatim: headache). The outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Menveo.     It was unknown if the company considered the headache to be related to Menveo.   Additional Information: GSK Receipt Date: 04-OCT-2023 The health care professional reported shortly after getting Menveo vaccine patient experienced headache. No other information was available. The reporter consented to follow up.
This is a spontaneous report from a contactable physician and a contactable consumer. This Physician reported similar events for ten patients. This is the second of ten reports. A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 11Jan2021 11:00 (also reported as 13Feb2021) (at the age of 65-years-old) as a single dose for COVID-19 immunization. The patient had no medical history or concomitant medications. The patient had no family history and no prior vaccinations. The patient was given the injection prepared with 3 mL sterile water and not with 1.8 physiological solution on 11Jan2021. The first vial they diluted with 3mL of sterile water, which was given to 6 patients. They realized the issue, calculated the concentration, and then prepared another vial with the correct amount of diluent (1.8mL) however they still used sterile water, and gave partial doses to the patients to give them the full correct concentration. There was enough vaccine in that vial, that 4 additional patients were given 30mcg doses (of the vaccine mixed with sterile water). They are planning to revaccinate these individuals. On 28May2021, the physician reported the patient provided information regarding the reported events with the use of BNT162B2. The physician stated that the patient self-administrated EpiPen for self-identified "anaphylaxis" on 11Jan2021 (also reported as 13Feb2021). The patient was observed for 30 minutes at 3-5-minute intervals post vaccination with the door open to main vaccination event site. She did not alert the nursing pharmacy individual or state of any distress but self-administered her EpiPen. When she was evaluated 5 minutes later -no rash, no respiratory distress, heart rate regular -100 (concomitant with EpiPen administration), blood pressure 130. She was observed for another 20-30 minutes with no symptoms. Although the self-administered EpiPen was inappropriate, the physician felt he/she was not advised to peruse dose 2, as the patient reported "anaphylaxis", but no physical findings were noted. Emergency room visit was not involved. The physician did not consider BNT162B2 to have a causal effect to the event. The outcome of the anaphylaxis was recovered.   Information on the Batch/Lot number has been requested.  Follow-up (25Feb2021): New information reported from a contactable consumer included: new reporter and additional information about the primary reporter.   Information on the Batch/Lot number has been requested.  Follow-up (28May2021): New information received from a contactable physician in response to HCP letter sent includes: patient data, test data, event information (new event: anaphylaxis), causality. Case upgraded to serious.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based on the available information there is no evidence or argument to suggest a causal relationship between the reported event of anaphylaxis and BNT162B2 administration.,Linked Report(s) : US-PFIZER INC-2021082099 same drug and event, different patient
4 days after the vaccine, pt developed a pruritic rash and some soreness in her hands.  Otherwise pt feels well.
4 days later had hives, swollen eyes temp 99.5 8 days later along with hives.
No adverse reactions reported.  To whom it may concern:  In November 2022 our state immunization program did our every-other-year audits in Both our offices. It was discovered at that time, that some Covid vaccines were administered outside of the 10 week expiration date (which is calculated from the date the vaccines were received from the state.) The state program directed us to fill out VAERS forms and send them to you. The state also counselled us that it was our providers and parents joint decision as to whether to re-vaccinate pts or not. We only use Pfizer vaccines for Covid - and the listed lot #'s given outside the expiration date are listed below. FM0698 (orange top)      FM0698 (purple) FM0698 (purple top)      FP4554 (purple) FL8095 (orange top)      FL8094 (orange) FL8094 (orange top)      FL8095 (orange) FM7553 (purple)           FT1551 (orange) Please see the attached VAERS forms, and feel free to contact the office for further questions or concerns.
This spontaneous report as received from a physician refers to unspecified patients. It was reported that unspecified patients were vaccinated with improperly stored MMR II (lot#, dose, strength and frequency were unknown) subcutaneous. No adverse effects were reported. Follow up information has been received from registered nurse. 61 unspecified patients received the improperly stored MMR II, lot #J003785 and expiration date: 28-MAR-2015. She states that the dates of administration of MMR II for the 61 unspecified patients were as followed: 09-JAN-2014, 13-JAN-2014, 14-JAN-2014, 15-JAN-2014, 17-JAN-2014, 20-JAN-2014, 21-JAN-2014, 22-JAN-2014, 24-JAN-2014, 27-JAN-2014, 28-JAN-2014, 29-JAN-2014, 31-JAN-2014, 03-FEB-2014, 05-FEB-2014, 06-FEB-2014, 10-FEB-2014, 11-FEB-2014, 12-FEB-2014, 13-FEB-2014, 20-FEB-2014, 21-FEB-2014, 24-FEB-2014, 25-FEB-2014, 26-FEB-2014, and 27-FEB-2014. This is one of several reports from the same source. Additional information has been requested.
A nurse reported pt received vaccine on 7/10/2000, on 7/11 pt awoke with injection site reaction characterized by redness, swelling, and tenderness at the injection site. Pt was also nauseous, then became dizzy and pale and had blurred vision these symptoms lasted approximately 5 minutes. Pt felt feverish, but did not take his temperature. His mother treated him with dihenhydramine, acetaminophen, and applications of ice to the injection site. By 07/12/2000, only the injection site swelling and tenderness remained. The pt's last injection of diphtheria and tetanus toxoids was in 1992. Concomitant vaccine given on 07/10/2000 is Engerix-B.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.   This case was linked to MOD-2021-395985 (Patient Link).
Intermittent dull pain at the injection site. The pain is very localized. The pain is about a 4 on a scale of 0 to 10 with 0 being no pain and 10 being the worst pain.  The pain happens daily and can last from 3 minutes to 30 minutes. It happens several times a day. Mostly in the afternoon. The pain goes away on its own. I am afraid to take any pain medication. The pain does not interfere with my daily functions.
Pain 8/10 pain scale/noticed 8/27/08 after 12pm.  No redness.  No induration.
Covid symptoms started 5/20/21 with body aches, headache, slight cough and fever. Tested positive 5/25/21 due to symptoms continuing. His symptoms are getting better, he is taking some pain meds to help with fever and the body aches. He has no underlying health conditions and wasn't seen at the hospital for covid-19. Vaccinated 4/8/21 with J&J.
Fot Flu shot 10/16/2001. On 10/21/2001 had coughing, hot feeling, sweating, flem in throat, light headedness and weakness. Has lasted four days so far. Not real sick, just slightly.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 72-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (received 1st dose in August 2018 at pharmacy) and SHINGRIX (received 2nd dose in October 2018 at his physician's office). In February 2019, the patient received the 3rd dose of SHINGRIX. In February 2019, less than a day after receiving SHINGRIX, the patient experienced influenza-like symptoms and extra dose administered. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved and the outcome of the extra dose administered was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX at an unknown deltoid. The patient got a call to get his 2nd dose from the pharmacy and got his 3rd dose of SHINGRIX in February 2019, which led to an extra dose administered. Later that night the patient experienced flu-like symptoms which resolved in about a day.
Feverish; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Feverish) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On 22-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen. On 23-Dec-2021, the patient experienced PYREXIA (Feverish). At the time of the report, PYREXIA (Feverish) outcome was unknown. Not Provided          No concomitant medication information was provided. It was unknown if patient was enrolled in a covid-19 vaccine trial. No treatment medication was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient put in the wrong date of birth and did not have ID to verify date of birth since she's a minor.
she had itching on her arm and she was rubbing it and then took the band aid off and she noticed a little rash.; she had itching on her arm and she was rubbing it and then took the band aid off and she noticed a little rash.; Caller states she was also tired and went to sleep.; Caller states she was also tired and went to sleep.; its swollen; There is a little red circle on the caller's arm.; states the pain and itching have resolved; Caller states she also got chills and she is usually cold due to being anemic and she gets chills anyway; This is a spontaneous report from a contactable consumer or other non hcp. A 75-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 29May2021 (Batch/Lot number was not reported) as 2nd dose, single dose for covid-19 immunisation. Medical history included anaemia she also got chills and she was usually cold due to being anemic. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (BNT162B2), via an unspecified route of administration on 08May2021 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. On 29May2021, the patient experienced rash and itching on her arm. On an unspecified date in May2021, the patient experienced chills, was tired, went to sleep, there was a little red circle on the caller's arm and it was swollen. She stated that after the second dose they put a band aid on the site and then she had itching on her arm and was rubbing it and then took the band aid off and noticed a little rash. She also stated that she did not scratch it very hard. Caller stated the pain and itching have resolved. Caller also stated that she was also tired and went to sleep and concerned with the side effects after the second dose since she did not have side effects with the first dose like she had with the second dose. The patient also reported that she was on a blood thinner and had to sit a half hour after she received the vaccine. Outcome of the event tired, went to sleep, there was a little red circle on the caller's arm and it was swollen was unknown at the time of this report. The events chills, pain and itching was resolved on unspecified date in May2021.
During vaccination, complained of left arm pain. After 45 min left arm pain continued with numbness in 3 middle fingers. Today feels reduced numbness and still pain in left arm, can't lift > 90 degrees.
second dose scheduled 42 days after the first; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled 42 days after the first) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled 42 days after the first). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled 42 days after the first) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided   Reporter did not allow further contact
Left arm numb and dysfunctional for 36 hours after vaccination; Left arm numb and dysfunctional for 36 hours after vaccination; Cannot move or do anything with left arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Left arm numb and dysfunctional for 36 hours after vaccination), LIMB DISCOMFORT (Left arm numb and dysfunctional for 36 hours after vaccination) and LIMB DISCOMFORT (Cannot move or do anything with left arm) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Left arm numb and dysfunctional for 36 hours after vaccination), LIMB DISCOMFORT (Left arm numb and dysfunctional for 36 hours after vaccination) and LIMB DISCOMFORT (Cannot move or do anything with left arm). At the time of the report, HYPOAESTHESIA (Left arm numb and dysfunctional for 36 hours after vaccination), LIMB DISCOMFORT (Left arm numb and dysfunctional for 36 hours after vaccination) and LIMB DISCOMFORT (Cannot move or do anything with left arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs were not reported.  No treatment information was reported.
Pt had a syncopal event with associated flushing/sweating. Vitals: 133/78, 72, 19, 98% on RA  -- > 12: 07 121/79, 74, 16, 98% on RA Pt given ammonia inhalant Pt stable and released from the vaccination site @12:07
Flushing, all over sensation of pins and needles, dizziness/shakiness, heart rate increased. Lasted for about 8 mins. Stayed in pharmacy for 20 mins, drank water. No more symptoms returned.
no additional Ae; Caller states the medical assistant who administered the GARDASIL9 stated she thought she administered "Hepatitis A vaccine".; This spontaneous report has been received form a nurse, referring to a 18-month-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications were not provided.  On 28-NOV-2022, the patient was inadvertently vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, 0,5 milliliter (lot number 1775827 has been verified to be a valid lot number, expiry date 27-JUN-2024) (strength, frequency, and administration route were not reported) instead of hepatitis a vaccine, inactivated (VAQTA) oral (strength, dose, frequency, lot number, and expiry date were not reported) (wrong product administered)indicated as prophylaxis.   No additional adverse events reported.
Dysautonomia symptoms, tachycardia, dehydration, labile blood pressure... about 1 week after second dose